Pharmacokinetics, drug interactions, and tolerability of valproate.
about
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanomaValproic acid improves second-line regimen of small cell lung carcinoma in preclinical modelsEffect of Sodium Valproate and Docosahexaenoic Acid on Pain in Rats.Efficacy and tolerability of injectable sodium valproate in patients with mania.Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?Can valproic acid be an inducer of clozapine metabolism?Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study.Combination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancerComparison of Valproic acid Clearance between Epileptic Patients and Patients with Acute Mania.The prince and the pauper. A tale of anticancer targeted agents.Three patients needing high doses of valproic Acid to get therapeutic concentrationsEarly post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury.
P2860
Q24658533-61F23B31-68FC-4A85-9E14-FB2D9BE4BA48Q28596812-6F95D12F-A15D-4BBA-A0A9-8B5C5618AD13Q33666428-F70E3922-9CBA-4152-9C6D-D36668DF86DBQ34034322-718D1614-B42D-4CED-9838-36FF9AAD36DDQ34284039-D488E427-8260-4805-9286-071C82402C96Q34497477-7078E904-02EE-4377-8A33-A5F780B736EEQ35835849-200F2787-8EBC-428B-AB8A-B832B96E003EQ36537920-A13138C2-DC0E-4323-8A26-862FE7B15A01Q36652523-9CADF912-0655-41D3-BAAA-ED8270F68596Q37042365-FF6E1E9D-D544-4E31-B358-D47C7434021EQ40523894-FEF4F530-0B1F-4CC1-8DAB-9A821F7C5365Q41542027-45B2F64B-6BF5-4935-B55D-5E8BE74BB726
P2860
Pharmacokinetics, drug interactions, and tolerability of valproate.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Pharmacokinetics, drug interactions, and tolerability of valproate.
@ast
Pharmacokinetics, drug interactions, and tolerability of valproate.
@en
type
label
Pharmacokinetics, drug interactions, and tolerability of valproate.
@ast
Pharmacokinetics, drug interactions, and tolerability of valproate.
@en
prefLabel
Pharmacokinetics, drug interactions, and tolerability of valproate.
@ast
Pharmacokinetics, drug interactions, and tolerability of valproate.
@en
P1476
Pharmacokinetics, drug interactions, and tolerability of valproate
@en
P2093
C Lindsay DeVane
P478
37 Suppl 2
P577
2003-01-01T00:00:00Z